Labcorp Appoints Novartis President to Board

By Ahmed Jameison • Monday, November 24 15:32 • Permanent Link

Labcorp (NYSE: LH) has appointed Victor Bulto, President, U.S. of Novartis, to its Board of Directors, effective December 1, 2025. Bulto brings 25 years of healthcare experience and oversees a $20+ billion operation at Novartis. Labcorp's Chairman and CEO, Adam Schechter, expressed confidence in Bulto's expertise, particularly in key therapeutic areas. Bulto, in turn, expressed belief in Labcorp's mission and is eager to contribute to the industry's growth and medical advancement, particularly in precision medicine.

Labcorp is a global leader in laboratory services, with nearly 70,000 employees serving clients in approximately 100 countries. The company provided support for over 75% of new drugs and therapeutic products approved in 2024 by the FDA and performs more than 700 million tests annually for patients worldwide.

Labcorp's focus on long-term growth through innovation and global healthcare leadership is evident in Bulto's appointment, emphasizing the company's commitment to advancing strategic priorities and innovating through science and technology to deliver greater value for customers and shareholders. Following these announcements, the company's shares moved -0.33%, and are now trading at a price of $264.77. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.